Related Experiment Video

Updated: Aug 17, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

[Epidemiologic, clinical and laboratory observations of some Streptococcus pneumoniae serotypes implicated in the

Letiţia Doina Duceac1, Stela Goţia, Gabriela Coman

  • 1Spitalul Clinic de Urgenţe Sf. Maria laşi, Compartimentul de Epidemiologie, Universitatea de Medicină si Farmacie Gr.T. Popa Iaşi, Facultatea de Medicină.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|July 12, 2005
PubMed

Insights

Pneumococcal vaccination (PNEUMO 23) in children with asthma reduced Streptococcus pneumoniae infections. This led to fewer asthma exacerbations and decreased disease severity.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Vaccinology

Context:

  • Asthma is a chronic respiratory condition in children, often exacerbated by infections.
  • Streptococcus pneumoniae is a common pathogen causing respiratory infections.
  • Vaccination strategies are crucial for managing childhood asthma and preventing infections.

Purpose:

  • To evaluate the impact of pneumococcal vaccination on Streptococcus pneumoniae carriage in children with asthma.
  • To assess the effect of vaccination on the frequency and severity of asthma exacerbations.
  • To determine the efficacy of PNEUMO 23 in preventing pneumococcal infections in this cohort.

Summary:

  • A study involved 103 children undergoing vaccination against Streptococcus pneumoniae.
  • Nasopharyngeal swabs revealed S. pneumoniae serotypes 6, 8, 14, and 19 in 39 children prior to vaccination.
  • Post-vaccination with PNEUMO 23, these strains were undetectable, alongside a reduction in pneumococcal infections.

Impact:

  • Vaccination significantly decreased the incidence of pneumococcal infections in children with asthma.
  • A notable reduction in asthma crises and overall disease severity was observed post-vaccination.
  • Pneumococcal vaccination emerges as a key intervention for improving asthma management and outcomes.

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: